Entero Healthcare Solutions Ltd
ENTEROEntero Healthcare Solutions Ltd
ENTERO
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,540 cr, stock is ranked 728
High RiskStock is 5.55x as volatile as Nifty
1,045.000.11% (+1.10)
1,045.000.11% (+1.10)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 314.43 | 7.60 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 43.83 | 5.97 | 0.59% |
Forecast & Ratings
Detailed Forecast100%
Analysts have suggested that investors can buy this stock
from 2 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Entero Healthcare Solutions is an India-based technology-driven and integrated healthcare products distribution company.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
PE Ratio
43.36
1Y Return
63.62%
Buy Reco %
80.00
Cipla Ltd
PE Ratio
27.41
1Y Return
51.42%
Buy Reco %
67.74
Zydus Lifesciences Ltd
PE Ratio
27.41
1Y Return
94.49%
Buy Reco %
42.31
Dr Reddy's Laboratories Ltd
PE Ratio
17.31
1Y Return
29.41%
Buy Reco %
36.36
Torrent Pharmaceuticals Ltd
PE Ratio
73.35
1Y Return
62.96%
Buy Reco %
76.00
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
2023
Current
₹1,043.90
Baseline
Forecast for May 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹
2023
Current
₹1,043.90
Baseline
Forecast for May 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹
Revenue Forecast
2023
Current
₹3.31
Baseline
Forecast for Mar 2024
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2023
Current
₹3.31
Baseline
Forecast for Mar 2024
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
Earnings Per Share Forecast
2023
Current
₹-29.04
Baseline
Forecast for Mar 2024
High
₹—
Median
₹—
Low
₹—
All values in ₹
2023
Current
₹-29.04
Baseline
Forecast for Mar 2024
High
₹—
Median
₹—
Low
₹—
All values in ₹
Income
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2021 | FY 2022 | FY 2023 | TTM | ||||
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,783.67 | 2,526.55 | 3,305.72 | 3,781.20 | ||||
Raw Materials | 1,685.19 | 2,342.47 | 3,051.26 | 3,671.98 | ||||
| Power & Fuel Cost | 3.39 | 4.07 | 4.25 | |||||
| Employee Cost | 75.94 | 114.81 | 128.14 | |||||
| Selling & Administrative Expenses | 21.31 | 33.75 | 34.50 | |||||
| Operating & Other expenses | -27.64 | 2.53 | 18.05 | |||||
EBITDA | 25.48 | 28.92 | 69.52 | 109.22 | ||||
| Depreciation/Amortization | 16.28 | 19.75 | 24.24 | 25.04 | ||||
| PBIT | 9.20 | 9.17 | 45.28 | 84.18 | ||||
| Interest & Other Items | 20.04 | 28.98 | 48.97 | 61.18 | ||||
| PBT | -10.84 | -19.81 | -3.69 | 23.00 | ||||
| Taxes & Other Items | 4.69 | 10.10 | 7.87 | 8.56 | ||||
| Net Income | -15.53 | -29.91 | -11.56 | 14.44 | ||||
| EPS | -1,549.90 | -151.44 | -29.04 | 35.12 | ||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Entero Healthcare Solutions Ltd | -392.76 | 7.60 | — |
| Sun Pharmaceutical Industries Ltd | 43.36 | 6.19 | 0.75% |
| Cipla Ltd | 27.41 | 4.76 | 0.93% |
| Zydus Lifesciences Ltd | 27.41 | 5.37 | 0.29% |
Price Comparison
Compare ENTERO with any stock or ETFCompare ENTERO with any stock or ETF
ENTERO
Shareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Sep 2023
Feb 2024
Mar 2024
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ENTERO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Articles & Videos
Hmm, looks like data is unavailable here. Please come back after some time.
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 26.41%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant